CYCLACEL PHARMACEUTICALS INC (CYCC) Stock Cash Flow
USA - NASDAQ:CYCC - US23254L8019 - Common Stock
6.365 USD
-0.4 (-5.98%)
6.4 USD
+0.04 (+0.55%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -6.41M | -11.21M | -22.55M | -21.20M | -18.89M | |||
| Depreciation Amortization | N/A | 6.00K | 31.00K | 30.00K | 40.00K | |||
| Change In Working Capital | -9.15M | 2.66M | 5.01M | -1.21M | -1.03M | |||
| Interest Paid | N/A | N/A | 266.00K | 210.00K | 20.00K | |||
| Taxes Paid | N/A | 2.00K | 2.00K | 3.31M | 1.36M | |||
| Other non cash items | 6.83M | 555.00K | 1.40M | 1.55M | 1.33M | |||
| OPERATING CASH FLOW | -8.73M | -7.99M | -16.11M | -20.83M | -18.54M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | N/A | -6.00K | -10.00K | -30.00K | |||
| Other Investing Activity | N/A | N/A | N/A | N/A | N/A | |||
| INVESTING CASH FLOW | N/A | N/A | -6.00K | -10.00K | -30.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 7.18M | 7.82M | 1.05M | 3.20M | 21.94M | |||
| Dividend Paid | N/A | N/A | -201.00K | -200.00K | -200.00K | |||
| FINANCING CASH FLOW | 7.14M | 7.82M | 848.00K | 3.00M | 21.74M | |||
| Exchange Rate Effect | -137.00K | -73.00K | 303.00K | -380.00K | -20.00K | |||
| CHANGE IN CASH | -1.73M | -241.00K | -14.97M | -18.22M | 3.15M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -8.73M | -7.99M | -16.11M | -20.83M | -18.54M | |||
| Capital Expenditure | N/A | N/A | -6.00K | -10.00K | -30.00K | |||
| FREE CASH FLOW | -8.73M | -7.99M | -16.12M | -20.84M | -18.57M | |||
All data in USD